Drugs / Enamel Matrix Proteins Derivative
Enamel Matrix Proteins Derivative
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT02972788 | Feb 2017 → Sep 2018 | periodontal disorder | University of Nebraska | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Enamel Matrix Proteins Derivative | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02972788 ↗ |
| Modality | Protein / enzyme biologic | “enamel matrix protein derivative” NCT02972788 ↗ |
| Route | Other | “Enamel matrix proteins derivative will be placed in deep periodontal pocket during routine periodontal maintenance therapy.” NCT02972788 ↗ |